Filter
173
Filtered Results: 173
Text search:
research
and
ethics
clearance
Featured
Recommendations
27
New Publications
47
Language
Document type
No document type
92
Guidelines
30
Studies & Reports
29
Manuals
13
Training Material
5
Strategic & Response Plan
4
Countries / Regions
India
14
Ethiopia
11
Global
10
Kenya
7
Sierra Leone
5
Nigeria
4
Tanzania
4
South Africa
4
Bangladesh
4
Ukraine
4
Cameroon
3
Uganda
3
Lesotho
3
Myanmar / Burma
3
East and Southern Africa
3
Liberia
2
Ghana
2
Zambia
2
Syria
2
Rwanda
2
Malawi
2
West and Central Africa
2
Middle East and North Africa
2
Western and Central Europe
2
Eastern Europe
2
Congo, Democratic Republic of
1
Haiti
1
Philippines
1
Pakistan
1
Germany
1
Cambodia
1
Thailand
1
Indonesia
1
Benin
1
Brazil
1
Botswana
1
Sri Lanka
1
South–East Asia Region
1
Latin America and the Carribbean
1
Africa
1
Southern Africa
1
Laos
1
Tajikistan
1
Russia
1
Moldova
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
89
Clinical Guidelines
18
Public Health
12
Women & Child Health
10
Key Resources
7
Capacity Building
1
Toolboxes
COVID-19
13
TB
12
Rapid Response
10
HIV
9
Ebola
8
NTDs
8
Mental Health
5
Pharmacy
5
Disability
4
Zika
4
Global Health Education
4
AMR
4
Caregiver
4
Conflict
3
Planetary Health
3
NCDs
3
Cholera
1
Natural Hazards
1
Refugee
1
Specific Hazards
1
Social Ethics
1
Introduction, preparations to submit, submission procedure, requirements, main narrative of the protocol, definition of terms. | For Research and ethics...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions fo...
These guidelines are applicable to all biomedical, social and behavioural science research for health conducted in India involving human participants, their biological material ... data.
The purpose of such research should be: i. directed towards enhancing knowledge about the human condition while maintaining sensitivity to the Indian cultural, social and natural environment; ii. conducted under conditions such that no person or persons become mere means for the betterment of others and that human beings who are participating in any biomedical and/or health research or scientific experimentation are dealt with in a manner conducive to and consistent with their dignity and well-being, under conditions of professional fair treatment and transparency; and iii. subjected to a regime of evaluation at all stages of the research, such as design, conduct and reporting of the results thereof.
February 2021.
Improving our response to the ongoing COVID-19 pandemic in Africa requires regularly updated information, constant innovation, and considerable support towards research ... development (R&D) for priorities that respond to the African realities. Shaping the research agenda and stimulating the generation, translation, and dissemination of valuable knowledge is one of the core functions of the African Academy of Sciences (AAS), African Centre for Disease Control (Africa CDC), and WHO-AFRO. We need answers to a list of critical research questions that respond to the current realities on the African continent to guide the COVID-19 outbreak control efforts
Accessed online January 2019, date of publication unknown.
Issues in Educational Research, 26(1), 2016
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
A report submitted to the International Labour Organization, Geneva
Post Graduate programme is essential to prepare nurses to improve the
quality of nursing education and practice in India. .
Post graduate programme in nursing builds upon and extends competence
a...
This report outlines the Ministry of Health’s National Health Research Agenda in which it identifies research priorities in health. It will be implemented in the same time frame as the Health Sect...
Report on Main Findings
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD ... in Myanmar; and 3) additional reviews of Myanmar ethical committee inquiries and postgraduate research on NCDs in Myanmar. This report outlines the key findings from the three components including a synthesis of the key outcomes from the literature review and qualitative interviews, and an assessment of the gaps in the evidence against a framework of evidence needs.
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD ... in Myanmar; and 3) additional reviews of Myanmar ethical committee inquiries and postgraduate research on NCDs in Myanmar. This report outlines the key findings from the three components including a synthesis of the key outcomes from the literature review and qualitative interviews, and an assessment of the gaps in the evidence against a framework of evidence needs.
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest ... financial investments for the priority research agenda across sectors for countries and funding bodies. The research agenda also serves as a guide to mitigate One Health AMR that will help policymakers, researchers, and a multidisciplinary scientific community work together on solutions to prevent and mitigate AMR within the One Health approach.
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, ... the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, ... the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks...
Ebola messages based on their qualitative research done in hotspot areas of Bombali and Urban Freetown, Jan-Feb 2015
Guidelines for Good Clinical Laboratory Practices (GCLP) outlines the principles and procedures to be followed by medical laboratories involved in clinical research .../or patient care so as to provide quality data which can be used for health research and patient treatment. As the use of laboratory tests (often expensive) are increasingly becoming a part of medical diagnosis and research, generation of quality data would be a cost-effective and ethically sound strategy.
Hindawi Publishing Corporation
Tuberculosis Research and Treatment
Volume 2015, Article ID 752709, 7 pages
